A detailed history of Advisors Asset Management, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 4,778 shares of NTRA stock, worth $804,854. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,778
Previous 4,064 17.57%
Holding current value
$804,854
Previous $440,000 37.95%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$97.75 - $129.67 $69,793 - $92,584
714 Added 17.57%
4,778 $607,000
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $346,577 - $457,606
4,064 New
4,064 $440,000
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $58,850 - $68,950
-1,250 Reduced 60.15%
828 $40,000
Q1 2023

May 12, 2023

SELL
$36.57 - $58.29 $8,374 - $13,348
-229 Reduced 9.93%
2,078 $115,000
Q3 2022

Nov 08, 2022

SELL
$36.93 - $56.68 $16,359 - $25,109
-443 Reduced 2.6%
16,592 $727,000
Q2 2022

Aug 08, 2022

SELL
$28.13 - $44.54 $34,093 - $53,982
-1,212 Reduced 6.64%
17,035 $604,000
Q1 2022

May 17, 2022

SELL
$30.32 - $91.33 $51,998 - $156,630
-1,715 Reduced 8.59%
18,247 $742,000
Q4 2021

Feb 15, 2022

SELL
$86.26 - $119.0 $1.42 Million - $1.96 Million
-16,511 Reduced 45.27%
19,962 $1.86 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $39,366 - $49,659
393 Added 1.09%
36,473 $4.07 Million
Q2 2021

Jul 30, 2021

BUY
$86.05 - $119.72 $246,361 - $342,758
2,863 Added 8.62%
36,080 $4.1 Million
Q1 2021

May 07, 2021

BUY
$91.47 - $124.36 $808,137 - $1.1 Million
8,835 Added 36.24%
33,217 $3.37 Million
Q4 2020

Feb 12, 2021

BUY
$66.66 - $111.74 $853,714 - $1.43 Million
12,807 Added 110.64%
24,382 $2.43 Million
Q3 2020

Nov 16, 2020

BUY
$45.89 - $72.67 $531,176 - $841,155
11,575 New
11,575 $836,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.